DossierENTITY

Argenx SE

Coverage of Argenx SE in the Nexus archive.

Earliest in view: Aug 17 · 08:03 UTCMost recent: Aug 17 · 08:03 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSAug 17 · 08:03 UTCBLOOMBERG
Argenx Soars on Latest Trial Success for Autoimmune Drug Vyvgart
Argenx SE's shares jumped after the European biotech reported a successful trial for its drug Vyvgart. The company reported that this was the latest large, successful trial conducted for the autoimmune drug.